CHG-2021-0204

New Dosage Strength for Semaglutidex. Formulation Change for Semaglutidex — minor update. Impacts 1 markets and 2 variations.

Change Number
CHG-2021-0204
Type
New Dosage Strength
Product
Semaglutidex
Status
Failed
Owner
Sarah Chen
Initiated
2024-02-04
Description

Formulation Change for Semaglutidex — minor update

Impacted Markets (1)
AT — Austria
Impacted Modules
3.2.P.33.2.P3.2.S2.3.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved